Cystic Fibrosis Questionnaire – Revised quality-of-life questionnaire

Eric WFW Alton; David K Armstrong; Deborah Ashby; Katie J Bayfield; Diana Bilton; Emily V Bloomfield; A Christopher Boyd; June Brand; Ruaridh Buchan; Roberto Calcedo; Paula Carvelli; Mario Chan; Seng H Cheng; David S Collie; Steve Cunningham; Heather E Davidson; Gwyneth Davies; Jane C Davies; Lee A Davies; Maria H Dewar; Ann Doherty; Jackie Donovan; Natalie S Dwyer; Hala I Elgmati; Rosanna F Featherstone; Jemyr Gavino; Sabrina Gea-Sorli; Duncan M Geddes; James SR Gibson; Deborah R Gill; Andrew P Greening; Uta Griesenbach; David M Hansell; Katharine Harman; Tracy E Higgins; Samantha L Hodges; Stephen C Hyde; Laura Hyndman; J Alastair Innes; Joseph Jacob; Nancy Jones; Brian F Keogh; Maria P Limberis; Paul Lloyd-Evans; Alan W Maclean; Michelle C Manvell; Dominique McCormick; Michael McGovern; Gerry McLachlan; Cuixiang Meng; M Angeles Montero; Hazel Milligan; Laura J Moyce; Gordon D Murray; Andrew G Nicholson; Tina Osadolor; Javier Parra-Leiton; David J Porteous; Ian A Pringle; Emma K Punch; Kamila M Pytel; Alexandra L Quittner; Gina Rivellini; Clare J Saunders; Ronald K Scheule; Sarah Sheard; Nicholas J Simmonds; Keith Smith; Stephen N Smith; Najwa Soussi; Samia Soussi; Emma J Spearing; Barbara J Stevenson; Stephanie G Sumner-Jones; Minna Turkkila; Rosa P Ureta; Michael D Waller; Marguerite Y Wasowicz; James M Wilson; Paul Wolstenholme-Hogg; on behalf of the UK Cystic Fibrosis Gene Therapy Consortium

Warning: The NCBI web site requires JavaScript to function. more...

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Alton EWFW, Armstrong DK, Ashby D, et al.; on behalf of the UK Cystic Fibrosis Gene Therapy Consortium. A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis. Southampton (UK): NIHR Journals Library; 2016 Jul. (Efficacy and Mechanism Evaluation, No. 3.5.)

Cover of A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis

A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis.

Show details

Contents

< Prev Next >

Appendix 4Cystic Fibrosis Questionnaire – Revised quality-of-life questionnaire

(PDF download)

Included under terms of UK Non-commercial Government License.

Bookshelf ID: NBK373656

Contents

< Prev Next >

PubReader
Print View
Cite this Page
Alton EWFW, Armstrong DK, Ashby D, et al.; on behalf of the UK Cystic Fibrosis Gene Therapy Consortium. A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis. Southampton (UK): NIHR Journals Library; 2016 Jul. (Efficacy and Mechanism Evaluation, No. 3.5.) Appendix 4, Cystic Fibrosis Questionnaire – Revised quality-of-life questionnaire.
PDF version of this title (37M)

Other titles in this collection

Efficacy and Mechanism Evaluation

Recent Activity

Clear Turn Off Turn On

Cystic Fibrosis Questionnaire – Revised quality-of-life questionnaire - A random...
Cystic Fibrosis Questionnaire – Revised quality-of-life questionnaire - A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis
Safety and adverse events - A randomised, double-blind, placebo-controlled trial...
Safety and adverse events - A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Bookshelf

A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis.

Appendix 4Cystic Fibrosis Questionnaire – Revised quality-of-life questionnaire

Views

Other titles in this collection

Recent Activity